Literature DB >> 30157014

Revised Self-Report Assessment of Functional Visual Performance (R-SRAFVP)-Part II: Construct Validation.

Marlene Snow1, Mary Warren2, Hon K Yuen3.   

Abstract

OBJECTIVE: Our objective was to validate the construct of the Revised Self-Report Assessment of Functional Visual Performance (R-SRAFVP) for older adults with low vision resulting from age-related eye disease.
METHOD: The 50-item draft of the R-SRAFVP was administered to 87 older adults with low vision. Construct validation included principal-components analysis and the known-groups method.
RESULTS: Principal-components analysis revealed nine components (comprising 33 items): Personal Care, Oral Care, Meal/Laundry Preparation, Financial Management, Telephone Usage, Personal Preference Activities, Reading, Writing, and Functional Mobility. Cronbach's α ranged from .72 to .84 for individual components and was .92 overall. Known-groups comparisons showed that participants with moderate to profound acuity loss or contrast sensitivity deficits reported significantly greater difficulty completing tasks on the R-SRAFVP than those with milder acuity loss or normal contrast sensitivity.
CONCLUSION: The 33-item R-SRAFVP demonstrates adequate evidence of reliability and validity to evaluate the ability of older adults with low vision to complete vision-dependent activities of daily living.
Copyright © 2018 by the American Occupational Therapy Association, Inc.

Entities:  

Year:  2018        PMID: 30157014     DOI: 10.5014/ajot.2018.030205

Source DB:  PubMed          Journal:  Am J Occup Ther        ISSN: 0272-9490


  2 in total

1.  Interventions Within the Scope of Occupational Therapy Practice to Improve Performance of Daily Activities for Older Adults With Low Vision: A Systematic Review.

Authors:  Chiung-Ju Liu; Megan C Chang
Journal:  Am J Occup Ther       Date:  2020 Jan/Feb

2.  Testing Activities of Daily Living (ADL) in Patients with Age-Related Macular Degeneration Undergoing Cataract Surgery: Lessons Learned from the Past and Development of a New Quality of Life (QOL) Test.

Authors:  Andreas F Borkenstein; Eva-Maria Borkenstein; Karen Murphy; Susan A Primo
Journal:  Clin Ophthalmol       Date:  2022-02-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.